Piramal Pharma Swings to Q2 Profit as Revenue Rises 28%
Piramal Pharma reported net profit of ₹5.58 crore for fiscal Q2 2026-27, compared with a year-ago loss of ₹99.2 crore. Revenue increased 28% year on year to ₹2,617 crore from ₹2,044 crore.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.